| Year |
Citation |
Score |
| 2023 |
Liu P, Wang W, Wang F, Fan J, Guo J, Wu T, Lu D, Zhou Q, Liu Z, Wang Y, Shang Z, Chan FL, Yang W, Li X, Zhao SC, ... ... Wu D, et al. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Journal of Translational Medicine. 21: 40. PMID 36681849 DOI: 10.1186/s12967-022-03860-3 |
0.407 |
|
| 2022 |
Wang W, Wu Q, Mohyeddin A, Liu Y, Liu Z, Ge J, Zhang B, Shi G, Wang W, Wu D, Wang F. Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. Computational and Mathematical Methods in Medicine. 2022: 5500416. PMID 36245843 DOI: 10.1155/2022/5500416 |
0.37 |
|
| 2022 |
Wang Y, Fan J, Chen T, Xu L, Liu P, Xiao L, Wu T, Zhou Q, Zheng Q, Liu C, Chan FL, Wu D. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. Frontiers in Endocrinology. 13: 975623. PMID 36034466 DOI: 10.3389/fendo.2022.975623 |
0.351 |
|
| 2022 |
Gao W, Wang Y, Yu S, Wang Z, Ma T, Chan AM, Chiu PK, Ng CF, Wu D, Chan FL. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. Stem Cell Research & Therapy. 13: 188. PMID 35526071 DOI: 10.1186/s13287-022-02864-6 |
0.454 |
|
| 2022 |
Yu YZ, Lv DJ, Wang C, Song XL, Xie T, Wang T, Li ZM, Guo JD, Fu DJ, Li KJ, Wu DL, Chan FL, Feng NH, Chen ZS, Zhao SC. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular Cancer. 21: 12. PMID 34986849 DOI: 10.1186/s12943-021-01480-x |
0.403 |
|
| 2021 |
Zhou J, Wang Y, Wu D, Wang S, Chen Z, Xiang S, Chan FL. Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer. Oncogene. PMID 33750894 DOI: 10.1038/s41388-021-01737-1 |
0.404 |
|
| 2020 |
Wang Z, Li Y, Wang Y, Wu D, Lau AHY, Zhao P, Zou C, Dai Y, Chan FL. Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells. Stem Cell Research & Therapy. 11: 123. PMID 32183880 DOI: 10.1186/S13287-020-01634-6 |
0.494 |
|
| 2019 |
Wang Z, Li Y, Wu D, Yu S, Wang Y, Leung Chan F. Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence. Oncogene. PMID 31695151 DOI: 10.1038/S41388-019-1080-3 |
0.536 |
|
| 2018 |
Xu Z, Wang Y, Xiao ZG, Zou C, Zhang X, Wang Z, Wu D, Yu S, Chan FL. Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer. Oncogene. PMID 30042415 DOI: 10.1038/S41388-018-0409-7 |
0.516 |
|
| 2018 |
Jia L, Wu D, Wang Y, You W, Wang Z, Xiao L, Cai G, Xu Z, Zou C, Wang F, Teoh JY, Ng CF, Yu S, Chan FL. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Oncogene. PMID 29555975 DOI: 10.1038/S41388-018-0198-Z |
0.535 |
|
| 2018 |
Xiao L, Wang Y, Xu K, Hu H, Xu Z, Wu D, Wang Z, You W, Ng CF, Yu S, Chan FL. Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis. Cancer Research. PMID 29438990 DOI: 10.1158/0008-5472.Can-17-2341 |
0.516 |
|
| 2018 |
Gao W, Wu D, Wang Y, Wang Z, Ma T, Chan FL. Abstract 2000: The regulatory role of endothelial nitric oxide synthase signaling in the growth of prostate cancer stem-like cells Cancer Research. 78: 2000-2000. DOI: 10.1158/1538-7445.Am2018-2000 |
0.508 |
|
| 2017 |
Wang F, Wu D, Fu H, He F, Xu C, Zhou J, Li D, Li G, Xu J, Wu Q, Chen J, Su L, Wang W, Zhang S. Cofilin 1 promotes bladder cancer and is regulated by TCF7L2. Oncotarget. 8: 92043-92054. PMID 29190896 DOI: 10.18632/oncotarget.20664 |
0.306 |
|
| 2017 |
Wang Z, Wu D, Ng CF, Teoh JY, Yu S, Wang Y, Chan FL. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer. Endocrine-Related Cancer. PMID 29042395 DOI: 10.1530/Erc-17-0280 |
0.537 |
|
| 2016 |
Wu D, Cheung A, Wang Y, Yu S, Chan FL. The emerging roles of orphan nuclear receptors in prostate cancer. Biochimica Et Biophysica Acta. PMID 27264242 DOI: 10.1016/J.Bbcan.2016.06.001 |
0.499 |
|
| 2016 |
Zhang S, Gera L, Mamouni K, Li X, Chen Z, Kucuk O, Wu D. Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644, an aminobisphosphonate derivative. Oncotarget. PMID 27050371 DOI: 10.18632/Oncotarget.8481 |
0.346 |
|
| 2016 |
Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, et al. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Nucleic Acids Research. PMID 26743006 DOI: 10.1093/Nar/Gkv1528 |
0.471 |
|
| 2015 |
Wu D, Yu S, Jia L, Zou C, Xu Z, Xiao L, Wong KB, Ng CF, Chan FL. Orphan nuclear receptor TLX functions as a potent suppressor of oncogene-induced senescence in prostate cancer via its transcriptional co-regulation of the CDKN1A (p21(WAF1) (/) (CIP1) ) and SIRT1 genes. The Journal of Pathology. 236: 103-15. PMID 25557355 DOI: 10.1002/Path.4505 |
0.539 |
|
| 2014 |
Yu S, Xu Z, Zou C, Wu D, Wang Y, Yao X, Ng CF, Chan FL. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization. The Journal of Pathology. 234: 514-25. PMID 25065497 DOI: 10.1002/Path.4413 |
0.446 |
|
| 2014 |
Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, Yew DT, Vanacker JM, Chan FL. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. The Journal of Pathology. 233: 61-73. PMID 24425001 DOI: 10.1002/Path.4329 |
0.513 |
|
| 2013 |
Yu S, Jia L, Zhang Y, Wu D, Xu Z, Ng CF, To KK, Huang Y, Chan FL. Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation. Cancer Letters. 328: 83-94. PMID 22995070 DOI: 10.1016/J.Canlet.2012.09.006 |
0.517 |
|
| 2013 |
Jia L, Wu D, Yu S, Chan FL. Abstract A21: Orphan nuclear receptor TLX recruits lysine-specific demethylase 1 to repress androgen receptor gene transcription and functions to promote hormone-resistant growth of prostate cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A21 |
0.51 |
|
| 2008 |
Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clinical and Investigative Medicine. MéDecine Clinique Et Experimentale. 31: E8-E15. PMID 18312749 |
0.414 |
|
| Show low-probability matches. |